tradingkey.logo

Edwards Lifesciences Corp

EW
View Detailed Chart

75.570USD

-0.470-0.62%
Market hours ETQuotes delayed by 15 min
44.48BMarket Cap
10.66P/E TTM

Edwards Lifesciences Corp

75.570

-0.470-0.62%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.62%

5 Days

+9.21%

1 Month

+3.73%

6 Months

+10.29%

Year to Date

+2.08%

1 Year

-12.57%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 33 analysts
BUY
Current Rating
80.388
Target Price
5.72%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Edwards Lifesciences Corp
EW
33
Boston Scientific Corp
BSX
34
Intuitive Surgical Inc
ISRG
33
Thermo Fisher Scientific Inc
TMO
33
Veeva Systems Inc
VEEV
32
Danaher Corp
DHR
28
1
2
3
...
18

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(2)
Buy(7)
Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
1.468
Neutral
RSI(14)
61.747
Neutral
STOCH(KDJ)(9,3,3)
86.742
Overbought
ATR(14)
2.620
Low Volatility
CCI(14)
160.834
Buy
Williams %R
9.944
Overbought
TRIX(12,20)
0.008
Sell
StochRSI(14)
87.703
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
73.554
Buy
MA10
72.033
Buy
MA20
71.154
Buy
MA50
71.701
Buy
MA100
71.564
Buy
MA200
72.481
Buy

News

More news coming soon, stay tuned...

Company

Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Company codeEW
CompanyEdwards Lifesciences Corp
CEOMr. Bernard J. Zovighian
Websitehttps://www.edwards.com